Trinity Biotech plc (TRIB)

Trinity Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5.78	3.69	6.58	25.91	27.33	15.23
Short-Term Investments	0	0	0	0	0	1.17
Cash & Cash Equivalents	5.78	3.69	6.58	25.91	27.33	16.4
Cash Growth	63.53%	-43.89%	-74.61%	-5.19%	66.63%	-45.83%
Receivables	17.32	13.9	15.75	16.12	22.67	20.99
Inventory	22.65	19.93	22.5	29.12	30.22	32.02
Other Current Assets	0.3	1.52	1.83	1.54	3.09	1.98
Total Current Assets	46.04	39.04	46.67	72.69	83.3	71.39
Property, Plant & Equipment	3.36	1.89	5.68	5.92	8.55	9.29
Goodwill and Intangibles	38.57	16.27	35.27	35.98	33.86	43.65
Other Long-Term Assets	2.33	2.23	4.49	4.31	4.69	6.74
Total Long-Term Assets	44.27	20.39	45.44	46.21	47.1	59.68
Total Assets	90.31	59.44	92.1	118.9	130.4	131.07
Accounts Payable	22.29	12.8	15.38	15.13	24.34	16.95
Current Debt	1.9	1.9	1.89	85.29	2.15	2.4
Other Current Liabilities	-1.37	0.33	0.08	0.07	0.57	0.1
Total Current Liabilities	22.82	15.04	17.34	100.49	27.06	19.45
Long-Term Debt	83.73	65.52	70.31	13.87	99.28	99.77
Other Long-Term Liabilities	6.61	2.83	6.63	4.86	6.28	7.14
Total Long-Term Liabilities	90.34	68.35	76.94	18.72	105.56	106.91
Total Liabilities	113.16	83.38	94.28	119.21	132.62	126.36
Total Debt	85.64	67.43	72.2	99.16	101.44	102.17
Debt Growth	11.31%	-6.61%	-27.19%	-2.25%	-0.72%	24.08%
Retained Earnings	-51.15	-48.64	-26.7	12.56	10.57	16.15
Comprehensive Income	-5.8	-5.71	-5.78	-5.38	-5.29	-3.93
Shareholders' Equity	-22.86	-23.95	-2.18	-0.32	-2.22	4.71
Net Cash / Debt	-79.86	-63.74	-65.62	-73.25	-74.11	-85.77
Working Capital	23.22	24.01	29.33	-27.8	56.24	51.94
Book Value Per Share	-3.00	-3.14	-0.52	-0.08	-0.53	0.98

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).